N@N

SuperGen to Present at Rodman & Renshaw Global Healthcare Conference on May 18th

^{Published on 2010-05-11 03:20:46 - Market Wire}
 

DUBLIN, Calif.--([ BUSINESS WIRE ])--SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at the Rodman & Renshaw 6th Annual Global Healthcare Conference on Tuesday, May 18^th in London.

SuperGen's presentation will begin at 11:55 a.m. British Summer Time / 3:55 a.m. Pacific Standard Time. A live webcast of the presentation will be available in the Investor Events section of the Company's Web site at [ www.supergen.com ]. The webcast will be archived for 30 days.

About SuperGen

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit [ http://www.supergen.com ].